SCHEMBL3741087

SCHEMBL3741087

COc1ccc2c(c1)/C(=N/O)c1c-2c(N2CCN(C(=O)CCNCCN(C)C)CC2)nc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 8/20 0.56
LMNA P02545 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
HSP90AA1 P07900 1/20 0.39
GAA P10253 1/20 0.38
USP2 O75604 1/20 0.38
HSD17B10 Q99714 1/20 0.38
POLB P06746 1/20 0.38
GFER P55789 1/20 0.37
MAPT P10636 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
TERT O14746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3741092 1.00 TOP1 (0.56) TOP1LMNAKDM4EALDH1A1HPGD
SCHEMBL3748969 0.90 TOP1 (0.51) TOP1LMNAKDM4EALDH1A1HPGD
SCHEMBL3737923 0.76 TOP1 (0.71) TOP1ALDH1A1MAPT
SCHEMBL3737922 0.76 TOP1 (0.71) TOP1ALDH1A1MAPT
SCHEMBL3746336 0.76 TOP1 (0.46) TOP1LMNAKDM4EALDH1A1HPGD
SCHEMBL3737470 0.72 TOP1 (1.00) TOP1
SCHEMBL3746327 0.71 TOP1 (1.00) TOP1TERT
SCHEMBL3738460 0.68 MEN1 (0.51) TOP1LMNAKDM4EALDH1A1HPGD
SCHEMBL3738459 0.68 MEN1 (0.51) TOP1LMNAKDM4EALDH1A1HPGD
SCHEMBL8810834 0.67 CYP1A2 (0.53) TOP1ALDH1A1USP2POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7829567-B2 Imino-indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2010-11-09 US claimed
US-7829567-B2 Imino-indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2010-11-09 US disclosed
US-20090111987-A1 Imino-Indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111987-A1 Imino-Indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same IMPA1, IMPDH1, IPO5 TOP1 265/4885LMNA 714/4885KDM4E 1726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.